XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 56,492 $ 34,054
Selling, general and administrative 23,022 11,961
Total operating expenses 79,514 46,015
Loss from operations (79,514) (46,015)
Other income (expense), net:    
Interest expense (55) (40)
Interest income 7,256 5,076
Other expense (87) (147)
Total other income, net 7,114 4,889
Net loss (72,400) (41,126)
Other comprehensive loss:    
Unrealized (loss) gain on short-term investments (974) 470
Comprehensive loss (73,374) (40,656)
Net loss attributable to common stockholders $ (72,400) $ (41,126)
Net loss per share attributable to common stockholders—basic $ (0.85) $ (0.59)
Net loss per share attributable to common stockholders—diluted $ (0.85) $ (0.59)
Weighted-average number of common shares used to compute net loss per share attributable to common stockholders —basic 85,213,200 69,438,890
Weighted-average number of common shares used to compute net loss per share attributable to common stockholders—diluted 85,213,200 69,438,890